From April 1, 2023 to June 30, 2023, the company has repurchased 57,335 shares, representing 1.82% for $0.13 million. With this, the company has completed the repurchase of 57,335 shares, representing 1.82% for $0.13 million under the buyback announced on January 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.01 USD | +6.91% | +19.64% | +39.58% |
Apr. 23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
Apr. 10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.58% | 5.72M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B | |
-6.32% | 8.35B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.